Cumulative Tau and Aβ pathologies, followed by cellular dysfunction in brain, lead to neurodegeneration which occurs shortly before clinical manifestation of AD, i.e., the onset of cognitive impairment [15]. This evidence concerns the gene MAPT and Alzheimer disease.